UnitedHealth Revenue Grows by $14 billion in 2024
Jul 16, 2024 · For the second quarter of 2024, UnitedHealth’s earnings reached $98.9 billion, up almost $6 billion from the same quarter last year. The increase, company executives said, reflect growth at Optum and UnitedHealthcare. Second quarter adjusted earnings from operations were $8.7 billion and include business disruption from the Change Healthcare cyberattack.
Understanding “Delinking” in the PBM Legislation | AMCP 2024
Apr 16, 2024 · Ross Margulies, J.D., M.P.H., a partner at the Foley Hoag law firm, discusses proposals to “delink” what pharmacy benefit managers are paid from the price of drugs.
UnitedHealthcare Adds Deductibles to Medicare Part D for 2025
Oct 3, 2024 · UnitedHealthcare is adding deductibles to Part D prescriptions on certain formulary tiers as a result of plan design changes from the Inflation Reduction Act.
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Nov 25, 2024 · CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Aetna Updates MA and Drug Programs for Medicare in 2025
Oct 1, 2024 · In 2025, Aetna, the health insurance company of CVS Health, has added several new programs to Medicare for 2025. Aetna will launch new Chronic Condition Special Needs Plans (C-SNPs) in Illinois (Chicago) and Pennsylvania (Philadelphia and Pittsburgh).
FDA Approves Attruby for Heart Failure Indication
Nov 25, 2024 · “Access to this new therapy means more hope and more opportunity to improve the lives of patients with amyloidosis,” Muriel Finkel, president of Amyloidosis Support Groups, a non-profit organization dedicated to the support of amyloidosis patients and caregivers, said in a news release.. Attruby is an oral small molecule stabilizer of transthyretin.
Prime Therapeutics Announces Rebranding, New Look
Sep 16, 2024 · Prime, headquartered in Eagan, Minnesota, is one of six largest pharmacy benefit managers (PBMs) in the country, an industry that has come under increasing criticism and scrutiny for its business practices and vertical and horizontal consolidation trends.
PTSD - managedhealthcareexecutive.com
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.
With New Drugs in the Offing, Treatment Cost of ATTR-CM Is …
Oct 16, 2024 · O’Shea said that the drug spend for ATTR-CM is low at this time because of the disease’s rarity. “But given that, even though utilization is going to be low [and] spend is going to be low, when we look at it in the aggregate of the rare disease category, we're seeing big increases,” O’Shea said.
Technology Emerges as Key Solution for Improving Specialty …
Oct 21, 2024 · Technology can help address the complexities of specialty medications by automating processes and enabling proactive interventions to ensure patients stay on their critical therapies, according to Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and …